SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-065890
Filing Date
2021-11-19
Accepted
2021-11-19 17:31:23
Documents
2
Period of Report
2021-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2156
2 POA DOCUMENT poa.txt EX-24 3539
  Complete submission text file 0001209191-21-065890.txt   7168
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Issuer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORMA THERAPEUTICS HOLDINGS, INC. 500 ARSENAL STREET, SUITE 100 WATERTOWN MA 02472
Business Address
Lee Frank D. (Reporting) CIK: 0001814686 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39988 | Film No.: 211429530